Interleukin-12p70 deficiency increases survival and diminishes pathology in Trypanosoma congolense infection

Journal of Infectious Diseases

Volumn 198, Issue 9, 2008, Pages 1284-1291

  Barkhuizen, Mark ^a   Magez, Stefan ^a,b   Ryffel, Bernhard ^c   Brombacher, Frank ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^c UNIVERSITÉ D'ORLÉANS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE; GAMMA INTERFERON; IMMUNOGLOBULIN G2A ANTIBODY; IMMUNOGLOBULIN G3 ANTIBODY; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 12P70; INTERLEUKIN 12P80; INTERLEUKIN 23; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; INFECTION CONTROL; MOUSE; NONHUMAN; PARASITEMIA; PRIORITY JOURNAL; PROTOZOAL INFECTION; SURVIVAL TIME; TRYPANOSOMA CONGOLENSE;

ANIMALS; ANTIBODIES, PROTOZOAN; IMMUNITY, INNATE; IMMUNOGLOBULIN G; INTERFERON-GAMMA; INTERLEUKIN-12; INTERLEUKIN-23; LIVER; MICE; MICE, KNOCKOUT; PARASITEMIA; PROTEIN SUBUNITS; TIME FACTORS; TRYPANOSOMA CONGOLENSE; TRYPANOSOMIASIS, AFRICAN;

EID: 54249127749     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/592048     Document Type: Article

References (31)

1. Sudarto MW, Tabel H, Haines DM. Immunohistochemical demonstration of Trypanosoma evansi in tissues of experimentally infected rats and a naturally infected water buffalo (Bubalus bubalis). J Parasitol 1990; 76: 162-7.
2. Losos GJ, Ikede BO. Review of pathology of diseases in domestic and laboratory animals caused by Trypanosoma congolense, T. vivax, T. brucei, T. rhodesiense and T. gambiense. Vet Pathol 1972; 9(Suppl):1-71.
3. Richards FF, Rosen NL, Onodera M, et al. Antigenic variation and the surface glycoproteins of Trypanosoma congolense. Fed Proc 1981; 40: 1434-9.
4. Shi M, Wei G, Pan W, Tabel H. Trypanosoma congolense infections: antibody-mediated phagocytosis by Kupffer cells. J Leukoc Biol 2004; 76:399-405.
5. Magez S, Radwanska M, Drennan M, et al. Interferon-γ and nitric oxide in combination with antibodies are key protective host immune factors during Trypanosoma congolense Tc13 infections. J Infect Dis 2006; 193: 1575-83.
6. Iraqi F, Sekikawa K, Rowlands J, Teale A. Susceptibility of tumour necrosis factor-alpha genetically deficient mice to Trypanosoma congolense infection. Parasite Immunol 2001; 23:445-51.
7. Kitani H, Black SJ, Nakamura Y, et al. Recombinant tumor necrosis factor alpha does not inhibit the growth of African trypanosomes in axenic cultures. Infect Immun 2002; 70:2210-4.
8. Guilliams M, Oldenhove G, Noel W, et al. African trypanosomiasis: naturally occurring regulatory T cells favor trypanotolerance by limiting pathology associated with sustained type 1 inflammation. J Immunol 2007; 179:2748-57.
9. Shi M, Pan W, Tabel H. Experimental African trypanosomiasis: IFN-gamma mediates early mortality. Eur J Immunol 2003; 33:108-18.
10. Brombacher F, Kastelein RA, Alber G. Novel IL-12 family members shed light on the orchestration of Th1 responses. Trends Immunol 2003; 24: 207-12.
11. Trinchieri G. Interleukin-12 and its role in the generation of TH1 cells. Immunol Today 1993; 14:335-8.
12. Stern AS, Podlaski FJ, Hulmes JD, et al. Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells. Proc Natl Acad Sci USA 1990; 87:6808-12.
13. Aggarwal S, Ghilardi N, Xie MH, de Sauvage FJ, Gurney AL. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem 2003; 278: 1910-4.
14. Mattner F, Fischer S, Guckes S, et al. The interleukin-12 subunit p40 specifically inhibits effects of the interleukin-12 heterodimer. Eur J Immunol 1993; 23:2202-8.
15. Holscher C. The power of combinatorial immunology: IL-12 and IL-12-related dimeric cytokines in infectious diseases. Med Microbiol Immunol 2004; 193:1-17.
16. Piccotti JR, Li K, Chan SY, et al. Alloantigen-reactive Th1 development in IL-12-deficient mice. J Immunol 1998; 160:1132-8.
17. Barkhuizen M, Magez S, Atkinson RA, Brombacher F. Interleukin-12p70- dependent interferon-gamma production is crucial for resistance in African trypanosomiasis. J Infect Dis 2007; 196:1253-60.
18. Mattner F, Magram J, Ferrante J, et al. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response. Eur J Immunol 1996; 26:1553-9.
19. Magram J, Connaughton SE, Warrier RR, et al. IL-12-deficient mice are defective in IFN gamma production and type 1 cytokine responses. Immunity 1996; 4:471-81.
20. Tabel H. Activation of the alternative pathway of bovine complement by Trypanosoma congolense. Parasite Immunol 1982; 4:329-35.
21. Dai WJ, Bartens W, Kohler G, Hufnagel M, Kopf M, Brombacher F. Impaired macrophage listericidal and cytokine activities are responsible for the rapid death of Listeria monocytogenes-infected IFN-gamma receptor-deficient mice. J Immunol 1997; 158:5297-304.
22. Radwanska M, Magez S, Michel A, Stijlemans B, Geuskens M, Pays E. Comparative analysis of antibody responses against HSP60, invariant surface glycoprotein 70, and variant surface glycoprotein reveals a complex antigen-specific pattern of immunoglobulin isotype switching during infection by Trypanosoma brucei. Infect Immun 2000; 68:848-60.
23. Naessens J, Kitani H, Momotani E, Sekikawa K, Nthale JM, Iraqi F. Susceptibility of TNF-alpha-deficient mice to Trypanosoma congolense is not due to a defective antibody response. Acta Trop 2004; 92:193-203.
24. Magram J, Sfarra J, Connaughton S, et al. IL-12-deficient mice are defective but not devoid of type 1 cytokine responses. Ann NY Acad Sci 1996; 795:60-70.
25. Satoskar AR, Rodig S, Telford SR 3rd, et al. IL-12 gene-deficient C57BL/6 mice are susceptible to Leishmania donovani but have diminished hepatic immunopathology. Eur J Immunol 2000; 30:834-9.
26. Adachi K, Tsutsui H, Kashiwamura S, et al. Plasmodium berghei infection in mice induces liver injury by an IL-12- and toll-like receptor/myeloid differentiation factor 88-dependent mechanism. J Immunol 2001; 167:5928-34.
27. Araujo MI, Bliss SK, Suzuki Y, Alcaraz A, Denkers EY, Pearce EJ. Interleukin-12 promotes pathologic liver changes and death in mice coinfected with Schistosoma mansoni and Toxoplasma gondii. Infect Immun 2001; 69:1454-62.
28. Hertz CJ, Mansfield JM. IFN-gamma-dependent nitric oxide production is not linked to resistance in experimental African trypanosomiasis. Cell Immunol 1999; 192:24-32.
29. Ghassabeh GH, De Baetselier P, Brys L, et al. Identification of a common gene signature for type II cytokine-associated myeloid cells elicited in vivo in different pathologic conditions. Blood 2006; 108:575-83.
30. Kaushik RS, Uzonna JE, Gordon JR, Tabel H. Innate resistance to Trypanosoma congolense infections: differential production of nitric oxide by macrophages from susceptible BALB/c and resistant C57Bl/6 mice. Exp Parasitol 1999; 92:131-43.
31. Uzonna JE, Kaushik RS, Gordon JR, Tabel H. Cytokines and antibody responses during Trypanosoma congolense infections in two inbred mouse strains that differ in resistance. Parasite Immunol 1999; 21:57-71.